Difference between revisions of "Transformation of PGE2 to 15-Keto-PGE2"

From ISMOC
Jump to: navigation, search
(15-PGDH Parameters)
(15-PGDH Parameters)
Line 83: Line 83:
 
Substrate: PGE2  
 
Substrate: PGE2  
 
|<ref name="Zhou2001"> [http://onlinelibrary.wiley.com/doi/10.1046/j.1432-1327.2001.02218.x/epdf Zhou H., C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.'' Eur J Biochem. 2001 Jun;268(12):3368-74.]</ref>
 
|<ref name="Zhou2001"> [http://onlinelibrary.wiley.com/doi/10.1046/j.1432-1327.2001.02218.x/epdf Zhou H., C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates.'' Eur J Biochem. 2001 Jun;268(12):3368-74.]</ref>
 +
|-
 +
|0.0055 ± 0.0006
 +
|<math> mM </math>
 +
|Human
 +
|Method:In vitro
 +
Expression Vector:  E. Coli
 +
pH:8
 +
Temperature: 25
 +
Substrate: PGE2 + NAD+
 +
|<ref name="Niesen2010"> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0013719 F. Niesen,, High-Affinity Inhibitors of Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships'' PLoS One. 2010 Nov 2;5(11):e13719.]</ref>
 
|-
 
|-
 
|}
 
|}
Line 96: Line 106:
 
! Reference
 
! Reference
 
|-
 
|-
|
+
|840
 
|<math> per minute </math>
 
|<math> per minute </math>
|
+
|Human
|
+
|Method: In vitro
|
+
Expression Vector:  E. Coli
|-
+
pH:8
 +
Temperature: 25
 +
Substrate: PGE2 + NAD+
 +
|<ref name="Niesen2010"> [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0013719 F. Niesen,, High-Affinity Inhibitors of Human NAD+-Dependent 15-Hydroxyprostaglandin Dehydrogenase: Mechanisms of Inhibition and Structure-Activity Relationships'' PLoS One. 2010 Nov 2;5(11):e13719.]</ref>
 
|}
 
|}
  

Revision as of 16:23, 28 September 2016

Return to overview

15-hydroxyprostaglandin dehydrogenase, also known as (15-PGDH) metabolises PG into the 15-Keto variant via a ketone reduction. The enzyme is constituently expressed in the skin (Finhelm1982) and within the eicosanoid network it is reported as metabolising PGE2 and PGF2a.

It should be noted that Judson et al found that 15-PGDH expression of the enzyme decreases in response to UVR (Judson2010).


Reaction

Catalysed by 15-PGDH

Chemical equation

 PGE2 \rightleftharpoons 15-Keto-PGE2

Rate equation

15-PGDH Parameters

Michaelis-Menten Constants
Value Units Species Notes Reference
0.008  mM Rat Skin Method:

pH:7.4 Temperature: 37'C Substrate: PGE2 + NAD+

[1]
0.0075  mM Rat Skin Method:

pH:7.4 Temperature: 37'C Substrate: PGE2 + NADP+

[1]
0.024  mM Rat Skin Method:

pH:7.4 Temperature: 37'C Substrate: PGF2a + NAD+

[1]
0.023  mM Rat Skin Method:

pH:7.4 Temperature: 37'C Substrate: PGF2a + NADP+

[1]
0.0039  mM Purified Human 15-PGDH Method: In vitro

Expression Vector: E. coli pH:7.5 Temperature: 37'C Substrate: PGE2

[2]
0.0099  mM Purified Rat 15-PGDH Method: In vitro

Expression Vector: E. coli pH:7.5 Temperature: 37'C Substrate: PGE2

[2]
0.0055 ± 0.0006  mM Human Method:In vitro

Expression Vector: E. Coli pH:8 Temperature: 25 Substrate: PGE2 + NAD+

[3]


Enzyme Turnover Numbers
Value Units Species Notes Reference
840  per minute Human Method: In vitro

Expression Vector: E. Coli pH:8 Temperature: 25 Substrate: PGE2 + NAD+

[3]
cPLA2 Abundance
Value Units Species Notes Reference
 ppm
Gibbs Free Energy Change
Value Units Species Notes Reference

References